Lynn Stockwell

Insider Reports History

Entity
Individual
Location
401 East Las Olas Blvd., Suite 1400, Ft. Lauderdale, FL
Signature
/s/ Lynn Stockwell
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lynn Stockwell:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Bright Green Corp Director, 10%+ Owner Common Stock 68.2M $24.5M $0.36 Jun 5, 2024 Direct
Bright Green Corp Director, 10%+ Owner Warrant (right to buy) 2.83M $368K $0.13 Sep 1, 2023 Direct
Drugs Made In America Acquisition Corp. CEO and Exe. Chair of Board, Director, 10%+ Owner Ordinary shares 4.19M Feb 18, 2025 Indirect
Bright Green Corp Director, 10%+ Owner Director Stock Option (right to buy) 122K May 23, 2024 Direct

Insider Reports Filed by Lynn Stockwell

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DMAA Drugs Made In America Acquisition Corp. Feb 18, 2025 2 $0 4 Feb 18, 2025 CEO and Exe. Chair of Board, Director, 10%+ Owner
DMAA Drugs Made In America Acquisition Corp. Jan 29, 2025 4 $0 4 Feb 4, 2025 CEO and Executive COB, Director, 10%+ Owner
DMAA Drugs Made In America Acquisition Corp. Jan 7, 2025 0 $0 3 Jan 10, 2025 Chief Executive Officer and Executive Chair of the Board, Director, 10%+ Owner
BGXX Bright Green Corp Jun 5, 2024 1 -$360K 4 Jun 10, 2024 Director, 10%+ Owner
BGXX Bright Green Corp May 23, 2024 1 $0 4 May 28, 2024 Director, 10%+ Owner
BGXX Bright Green Corp Jul 18, 2023 5 $3.5M 4 Sep 6, 2023 Director, 10%+ Owner
BGXX Bright Green Corp May 30, 2023 1 $0 4 Jun 15, 2023 Director, 10%+ Owner
BGXX Bright Green Corp Feb 6, 2023 2 $0 4 Jun 1, 2023 Director, 10%+ Owner
BGXX Bright Green Corp Dec 31, 2022 4 $0 5 Feb 14, 2023 Director, 10%+ Owner
BGXX Bright Green Corp May 13, 2022 0 $0 3 May 13, 2022 Director, 10%+ Owner